The human prostatic cancer cell line LNCaP and its derived sublines: An in vitro model for the study of androgen sensitivity
- 31 December 1991
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 40 (1-3) , 207-214
- https://doi.org/10.1016/0960-0760(91)90184-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormonesThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell lineThe Prostate, 1990
- Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaPUrological Research, 1989
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- Application of the MTT assay to human prostate cancer cell lines in vitro: Establishment of test conditions and assessment of hormone‐stimulated growth and drug‐induced cytostatic and cytotoxic effectsThe Prostate, 1988
- Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaPThe Prostate, 1988
- Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐rThe Prostate, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Methyltrienolone, a specific ligand for cellular androgen receptorsSteroids, 1975